The present report is a study on the side effects experienced by the patients attending the Lithium Clinic of the Institute of Psychiatry, Government Rajaji Hospital, Madurai. Out of the 120 (M 78, F42) patients studied, 97 had side effects. The effects were examined in respect of their frequency, time of onset and course, their relation to tne dose and serum levels oflithium and to the clinical response. The duration of therapy ranged from 3 months to 6 years.
Lithium, the most preferred agent in prophylaxis of manic depressive psychosis lias been an extensively studied drug in Psychiatry. It is to mood disorders what antibiotics are to infections. Lithium exerts numerous effects on the psysiologica] systems. Some of these are directly or indirectly related to its psychotropic action and also cause side effects during therapy. Side effects, mostly somatic, are quite common with lithium as with other psychotropic drugs (NIMH Report, 1970 ; Christodoulou etal., 1977; Fieve 1979) . While some occur early and are transient, others appeal later, tending to persist.
The present communication is a report on the side effects experienced by the patients 'bserved in the Lilhium Clinic of the Madurai Medical College and Government Rajaji Hospital, Madurai, India, during the last seven years. Earlier publications from this clinic include studies on clinical response to lithium Venkoba Rao et al., 1982 (a) •Asst. Prof, of Psychiatry, Institute of Psychiatry.
•} renal structure and functions and on memory defects (Venkoba Rao etal., 1979 , 1981 Venkoba Rao and Hariharasubramanian, 1980; Hariharasubramanian etal., 1978; Srinivasan etal., 1978; Sugumar etal., 1980) .
AIM, MATFRIAL AND METHOD
The present study examines the side effects of lithium in respect of their frequency, time of onset and course, their relation to the dose and serum levels of lithium and to the clinical symptomatology of 120 patients who form the material for the study. The side effects noticed in the earlier patients in the clinic have been reported elsewhere (Venkoba Rao and Hariharasubromanian 1978; Venkoba Rao et al 1982a) . The age of the patients ranged from 21-63 years (Mean : 39.5) (Bipolars-113, Unipolar manics-3, Unipolar depressives-4). Tl:e oral dose of lithium ranged fnm 750-1000 mgm/day and the serum lithium, periodically estimated, was in the range of 0.6-1.2 mmols/litre. The duration of therapy ranged from 3 months Govt. Rajaji Hospital and Madurai Medical College, Madurai. to 6 years. The patients received in addition, phenothiazines and tricyclics occasionally.
OBSERVATIONS
The side effects are listed in order of frequency of occurrence in Table 1 . Of the 120 patients, 97 had side effects (80.8%) while 23 had no side effects so far. More than one spmptom was reported by 17 (14.2%). The side effects relate to neuromuscular and CNS (Tremorcs, memory defects, gait, tardive dyskinesia), gnstro intestinal (nausea, abdominal discomfort, loose bowels, excess salivation), endocrine and metabolic systems (hypothyroidism, weight gain), water balance (polyuria/polydipsia) and skin (acne, fall of hair). Symptoms such as tremor, salivation and G. I. tract disturbances occurred early, within the first three months of initiation of therapy, whereas memory defects, weight gain, polyuria and gait disturbances appeared between 3 months to one year (Table II) . Late, (upto 3 months) (3 months-1 year) (after 1 year).
Tremor
Memory defects. Hypothyroidism.
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Excess salivation, acne, gastrointestinal disturbances and gait problems were transient and settled spontaneously. Memory deficit, viz., impairment of short term recall at 15-second interval, lasted longer but became less disturbing as days passed. These memory defects have been earlier reported by us (Sugumar et al., 1980) . Tremors : (N=32) : Fine tremor, usually of fingers was the commonest symptom, noted quite early during therapy. In seven patients the tremors were controlled with 40 mg propranolol per day which was discontinued after 2-3 months and tremors did not recur. In others, the magnitude of the tremors diminished over time and settled without any measure to counter. Two patients developed marked tremulous ataxia. Mrs. B. who was free from tremors during a continuous period of 2.5 years of therapy with lithium and subsequently during a seven month drugfree period experienced scvcie tremors within a week of restarting lithium; the serum lithium was 1.6 mMol/litre when she had severe tremors. The second patient, Mr. M., had tremors within four days of starting on lithium for the first time. This patient received amitryptiline in addition and the serum lithium was 0.9 mMol/litre. Lithium was withdrawn from both of them resulting in cessation of tremors. In the first patieni lithium was restarted after tremors subsided and during the six months of treatment till date, tremors have not reippeared.
Polyuria : (N=25) : Polyuria (24 hours urine volume : 3.2-4 litres) was reported by 25 patients. Renal function was investigated in all the patie its and did not reveal any gross impairment. The polyuria wr.s reversible (Ve.ikoba Rao et nl, 1979) . Renal biopsy do..e on 13 of these patients showed nonspecific renal changes (Venkobu Rao et nl, 1981) .
Weight gain : (N=9) :
Weight gain was noted in 9 patients, with an average of 4.5 kg. (3-7 kgs). The increase was gradual over a period of 2-3 months. After the initial increase, however, there was a plateau : Over the next few months they returned to the pretrea tment level.
Hypothyroidism : (N=7) : Seven patients developed clinical features of hypothyroidism including goitre, skin changes and fall of hair, over a period of 1.5-2.5 years of therapy (Mean : 1.7 years). They were treated with thyroid; lithium was continued without any further impairment of thyroid function. Clinical features of hypothyroid state receded.
Relation to Serum levels and dosage of lithium : All the side effects were experienced while the oral dose of lithium was 750-1000 me/day in 3 divided doses and the serum lithium levels well within the range of 0.6 -1.2 mMol/litre. There was no correlation between these and any specific side effects.
Relation to Clinical Response : Out of the 120 patients, 43, who were continuously on lithium for 4 years or more, were chosen for examining side effects reported by them in relation to their clinical response. They were divided into two groups-Group I & Group II. Group I maintained remission without any relapse and Group II suffered relapses during therapy. Table III shows the observations. Of the 43 on long term therapy, 13 were good responders (Group I) with no relapses; of these 10 (77%) had side effects. Of the 30 moderate responders (Group II), 22 (70%) had side effects. The difference in incidence between the groups was not statistically significant. In the Group I the incidence of G. I. problems, tremors and polyuria was significantly higher than in the Group II. In the latter, however, endocrine and metabolic effects were more frequent (54.5%) than in Group I (40%).
DISCUSSION
The gastrointestinal problems of nausea, looseness of bowel.-, and abdominal discomfort are said to occur in conjunction with the absorption of the ion and its rising blood concentrations.
While mild hypermo'.ility of the intestines, nausea and changes in appetite can occur even with low serum levels, frank diarrhoea and vomiting indicate imminent toxicity and call for stopping lithium (NIMH report 1970; Schou, 1976) . The hitter symptoms did not occur in the patients we studied.
Tremors and polyuria were the most frequent symptoms in the patients, as in certain other reports. A significant reduction in these symptoms following discontinuation of lithium has been suggested as evidence that they are genuine side effects due to lithium (Christodoulott and Lykouras, 1982) . In our study too, the severe tremors experienced by two patients disappeared on withdrawal of lithium confirming the trcmorigenic role of Lithium. Hand tremors during lithium therapy have a frequency different from Parkinsonian tremors and are believed to be non-extrapyramidal (Asnis et al., 1979) . They are not relieved by anticholinergics but arc amenable to beta-blockers (Schou, 1976) . The present study confirmed this. Betablockers may be discontinued after reduction in tremors without recurrence of tremors in many. In intoxication, the fine tremors progress to coarse tremors and predispose to cogwheel rigidity (Schou et al., 1976; Asnisctal., 1979) .
Tardive dyskinesia, noted in 4 cases of our series mitigated without any specific treatment. This is of interest in the context of reports that lithium might be of benefit in tardive dyskinesia (Reda et al., 1975) . There are reports of extrapyramidal features during lithium therapy (Shopsin and GersJ-.on, 1975; Branchey et al., 1976 and Asnis et al., 1979) , and also on aggravation of pre-existing tardive dyskinesia by lithium with near toxic levels (Crews et ah, 1977) .
Memory defects, observed earlier in our study (Sugum; T et al., 1980) and by others (Judd et al., 1979; Kusumo and Vaughan, 1977) arc not severe and tend to clear over time. Others report no significant memory problem:; during lithium therapy (Telford and \Vorrall, 1978; Engelsmann, 1980; Singh etal., 1982) .
Lithium induced hypothyroidism and goiter have been described by many investigators (Schou et al., 1976; Fieve and Platman, 1968, 1969) . The reported incidence of hypothyroidism varies from 6-30% (Lindstedt et al., 1977) . In this study it is about 9% (N = 7) out of the 78 patients who were on treatment for more than 1.5 years (the mean time of onset of hypothyroidism being 1.7 years of therapy in the present study), lower than the higher incidence (30%) reported by Fieve and Platman (1968,1969) . In these studies, estimations of thyroid hormones in blood have enabled detection of latent hypothyroidism also. Our study has been limited to clinically manifest case. The anti-thyroid effect of lithium is inherent in its anti manic effect. Lithium inhibits release of thyroxine and reduces the intra-thyroid indothyronine/ iodotyrosine ratio (Sedvall etal, 1968) . Latent hypothyroidism is believed to set in early as a natural physiological sequel, corrected by the pituitary thyroid axis (NIMH report, 1970 ). An increase in TRH and TSH occurs secondarily and restores the balance; A few cases of transient thyrotoxicosis consequent on increase in TRH and TSH have been reported as evidence of an overadaptive response to lithium, induced hypothyroidism (Reus et a!., 1979; Brownlie et al., 1976; Rosser, 1976) .
Weight gain has been reported to be a frequent effect of lithium treatment (Kerry etal., 1970; Grof et al., 1973; Vendsborg et al., 1976) . In the present study, only 9 out of 120 (7.5%) have gained weight more than 3 kg between 3 months to 1 year of treatment. Changes in lipid metabolism, increase in serum mrgnesium and calcium and changes in carbohydrate metabolism with increased glucose tolerance (Mellerup etal., 1973; Vendsborg, 1979) have been suggested to be associated with weight increase. A metabolic readjustment is presumed to occur, since after an initial increase, the gain reaches a plateau and slowly returns to the prc-treatment weight levels.
In the present study, there has been no occasion to study foetal anomalies due to lithium. The 42 females included unmarried girls, widows and divorced women who are not remarried, patients who have had tubectomy and post-menopausal women; others did not conceive during the period of lithium therapy.
RELATION TO DOSE AND SERUM LEVELS:
All the patients received regular preparations of lithium consuming the daily requirement in two or three divided doses. As such any spec fie advantage of single dose .schedule over the divided dose regimen can not be made out from this study. Mellerup et al. (1979) observed that tremor, polyuria and weight gain are seen both in patients taking single daily doses as well as in those taking two or three doses. Except in two of the patients the side effects in the present study were not severe enough to warrant discontinuation of treatment. No specific relation has been detected between serum levels and side effects. In some reports tremor, nausea and abdominal discomfort were found to be related to the peak levels cf serum lithium (Persson, 1977) whereas this was not found by others (Edstrom & Persson, 1977; Fyro et al., 1970) .
RELATION TO CLINICAL RESPONSE Ananth et al. (1977) observe that there is a greater incidence of side effects in the responders and that they tended to experience more endocrine side effect.? than the non-respondcrs. Grof et al. (1973) report a positive association betwee.i weight gain and response to lithium. The findings of the present study on the other hand indicate a higher occurrence of neurological, gastrointestinal and renal side effects in the good responders and endocrine and metabolic effects (hypo- 
